Gene transfer to the vasculature: historical perspective and implication for future research objectives
Related Experiment Video
Updated: Sep 28, 2026
In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium
Published on: May 6, 2018
Sarah J George1, Andrew H Baker
1Bristol Heart Institute, Bristol Royal Infirmary, UK.
Insights
Vascular gene therapy offers a promising new approach for treating cardiovascular diseases when drugs fail. Research is advancing rapidly, focusing on effective gene delivery vectors for future human treatments.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Biotechnology
Background:
- Cardiovascular diseases (CVDs) represent a significant global health burden, causing substantial mortality, disability, and economic impact.
- Current pharmacological treatments for many CVDs are limited in efficacy or unavailable.
- Significant advancements in vascular gene transfer offer potential new therapeutic avenues.
Purpose of the Study:
- To review the progress in preclinical vascular gene therapy.
- To identify and discuss suitable gene delivery vectors for cardiovascular applications.
- To outline the challenges and future directions for developing safe and efficient vascular gene therapies for CVDs.
Main Methods:
- Review of preclinical studies in vascular gene therapy.
- Analysis of various gene delivery vectors (e.g., viral, non-viral).
- Discussion of clinical trial progress and associated obstacles.
Main Results:
- The field of vascular gene transfer has seen remarkable progress, primarily in preclinical research.
- Several gene delivery vectors have been evaluated, with ongoing efforts to optimize their efficiency and safety.
- Early-stage clinical trials are underway, indicating a transition from preclinical to clinical application.
Conclusions:
- Vascular gene therapy holds unprecedented potential for treating a wide range of cardiovascular diseases.
- Overcoming scientific, clinical, and ethical hurdles is crucial for realizing the full potential of gene therapy.
- Continued research into optimized gene delivery vectors is essential for achieving safe and effective human cardiovascular gene therapies.
Abstract:
Cardiovascular diseases are a major cause of fatality, disability, and economic burden in Western civilization. Although the pharmaceutical industry has delivered a plethora of drugs for treatment of diverse cardiovascular complaints, there remain many conditions for which pharmacological regimens are either nonexistent or largely ineffective. In contrast, remarkable progress has been made in the field of vascular gene transfer in the last decade. The vast majority of studies are preclinical, although a number of high profile vascular gene therapy clinical trials are in progress. In principle, vascular gene therapy represents an unprecedented opportunity to treat a host of cardiovascular diseases in humans although many scientific, clinical, and ethical obstacles remain. Here we discuss the rapid progress in preclinical vascular gene therapy, highlight the most appropriate gene delivery vectors, and discuss the advances toward the ultimate goal of an efficient and safe gene therapy for diverse cardiovascular diseases.
Related Concept Videos
01:10Mechanism of Angiogenesis
01:24Regulation of Angiogenesis and Blood Supply